AVALYN PHARMA INC

AVLNNASDAQ

🏆 #1885 by market capEarnings Sep 2US Equity

$35.46▲ $0.92 (+2.60%)

🌅 Pre-market$35.00▼ 1.30%Regular close · extended-hours price shown

1h—

24h▲ 2.6%

7d▲ 11.1%

14d▲ 26.4%

30d▲ 26.8%

1y—

🏦Market Cap

$1.57B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

59

Weak

Earnings

Q2 · 2026Reported 2026-06-03

Earnings Per Share

Actual

-21.83

Expected

-5.98

miss

−265.30%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates